TTM
−$34.01M
YoY change
-35.0%
5Y CAGR
—
Peak year (2018)
−$9.97M
Cumulative operating income
−$298.49M
Operating Income history chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: −$36.51M
Operating Income growth chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: -35.0%
Operating Income history table for Spruce Biosciences (SPRB) from 2018 to 2025
| 2025 | −$36.51M | -35.0% | +$19.64M | ||
| 2024 | −$56.15M | +8.0% | −$4.16M | ||
| 2023 | −$51.99M | +10.0% | −$4.71M | ||
| 2022 | −$47.28M | +12.4% | −$5.22M | ||
| 2021 | −$42.07M | +43.0% | −$12.65M | ||
| 2020 | −$29.42M | +124.4% | −$16.31M | ||
| 2019 | −$13.11M | +31.4% | −$3.13M | ||
| 2018 | −$9.97M | — | — |
- 2025−$36.51M-35.0%
- 2024−$56.15M+8.0%
- 2023−$51.99M+10.0%
- 2022−$47.28M+12.4%
- 2021−$42.07M+43.0%
- 2020−$29.42M+124.4%
- 2019−$13.11M+31.4%
- 2018−$9.97M—
Operating Income values are taken from Spruce Biosciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Spruce Biosciences (SPRB)
According to Spruce Biosciences's latest reported financial statements, the company's current operating income (TTM) is −$34.01M. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Spruce Biosciences (SPRB) operating income is −$36.51M – plunged 35.0% year-over-year.
Across the available history, operating income reached its high of −$9.97M in 2018 and its low of −$56.15M in 2024.
Spruce Biosciences Operating Income by Year
Spruce Biosciences Operating Income 2025: −$36.51M
2025's operating income for Spruce Biosciences came in at −$36.51M, plunged 35.0% below 2024.
Spruce Biosciences Operating Income 2024: −$56.15M
Spruce Biosciences posted operating income of −$56.15M in 2024, grew 8.0% from 2023. This figure represents the lowest annual value in the available history.
Spruce Biosciences Operating Income 2023: −$51.99M
In 2023, Spruce Biosciences reported operating income of −$51.99M, grew 10.0% from 2022.
Spruce Biosciences Operating Income 2022: −$47.28M
Spruce Biosciences operating income in 2022 was −$47.28M, grew 12.4% from 2021.
Spruce Biosciences Operating Income 2021: −$42.07M
Spruce Biosciences operating income in 2021 was −$42.07M.
See more financial history for Spruce Biosciences (SPRB).
Sector peers by Operating Income
Healthcare peers of Spruce Biosciences (SPRB), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation